Biohaven EPS - Earnings per Share 2016-2022 | BHVN
Biohaven eps - earnings per share from 2016 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Biohaven Annual EPS |
| 2021 |
$-13.09 |
| 2020 |
$-13.06 |
| 2019 |
$-10.91 |
| 2018 |
$-6.15 |
| 2017 |
$-5.00 |
| 2016 |
$-5.05 |
| 2015 |
$-0.91 |
| Biohaven Quarterly EPS |
| 2022-09-30 |
$-1.75 |
| 2022-06-30 |
$-6.21 |
| 2022-03-31 |
$-2.97 |
| 2021-12-31 |
$-4.21 |
| 2021-09-30 |
$-1.38 |
| 2021-06-30 |
$-3.23 |
| 2021-03-31 |
$-4.27 |
| 2020-12-31 |
$-3.64 |
| 2020-09-30 |
$-3.27 |
| 2020-06-30 |
$-3.08 |
| 2020-03-31 |
$-3.07 |
| 2019-12-31 |
$-2.79 |
| 2019-09-30 |
$-2.04 |
| 2019-06-30 |
$-4.67 |
| 2019-03-31 |
$-1.41 |
| 2018-12-31 |
$-1.29 |
| 2018-09-30 |
$-1.53 |
| 2018-06-30 |
$-1.01 |
| 2018-03-31 |
$-2.32 |
| 2017-12-31 |
$-0.29 |
| 2017-09-30 |
$-1.19 |
| 2017-06-30 |
$-1.78 |
| 2017-03-31 |
$-1.74 |
| 2016-12-31 |
$-2.09 |
| 2016-09-30 |
$-2.16 |
| 2016-06-30 |
$-0.55 |
| 2016-03-31 |
$-0.25 |
| 2015-12-31 |
$0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.913B |
$0.463B |
|
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
|
